Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. | 127 665 | déclaré | 31 janv. 2026 | tx 19+1 463 400−193 949 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 31 janv. 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 58 050 | — | |
| 31 janv. 2026 | TAX_WITHHOLDING | Atea Pharmaceuticals, Inc. | 14 136 | 4.24 USD | |
| 31 janv. 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 11 250 | 0.00 USD | deriv |
| 31 janv. 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 46 800 | 0.00 USD | deriv |
| 31 janv. 2026 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 177 000 | 0.00 USD | deriv |
| 31 janv. 2025 | EXERCISE | Atea Pharmaceuticals, Inc. | 46 800 | — | |
| 31 janv. 2025 | TAX_WITHHOLDING | Atea Pharmaceuticals, Inc. | 14 134 | 3.06 USD | |
| 31 janv. 2025 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 11 250 | — | |
| 31 janv. 2025 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 11 250 | 0.00 USD | deriv |
| 31 janv. 2025 | EXERCISE | Atea Pharmaceuticals, Inc. | 46 800 | 0.00 USD | deriv |
| 31 janv. 2025 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 200 000 | 0.00 USD | deriv |
| 01 févr. 2024 | SALE | Atea Pharmaceuticals, Inc. | 14 029 | 3.84 USD | |
| 31 janv. 2024 | EXERCISE | Atea Pharmaceuticals, Inc. | 46 800 | — | |
| 31 janv. 2024 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 225 200 | 0.00 USD | deriv |
| 31 janv. 2024 | EXERCISE | Atea Pharmaceuticals, Inc. | 46 800 | 0.00 USD | deriv |
| 31 janv. 2023 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 140 400 | 0.00 USD | deriv |
| 31 janv. 2023 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 196 600 | 0.00 USD | deriv |
| 31 janv. 2022 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 190 000 | 0.00 USD | deriv |
| 29 janv. 2021 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 160 050 | 0.00 USD | deriv |